Lorraine Sullivan
13Patents
7h-index
8Co-inventors
59Inventor score
Filing activity: Mar 28, 1997 → Mar 3, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8735539B2 | Relaxin polypeptides comprising non-naturally encoded amino acids | Emerging Cross-Sectional Technologies | 34 | Active |
| US5787507A | Headgear stabilising and ventilating apparatus | Human Necessities | 16 | Expired |
| US9452222B2 | Nucleic acids encoding modified relaxin polypeptides | Emerging Cross-Sectional Technologies | 15 | Active |
| US9567386B2 | Therapeutic uses of modified relaxin polypeptides | Human Necessities | 15 | Active |
| US10253083B2 | Therapeutic uses of modified relaxin polypeptides | Human Necessities | 10 | Active |
| US9962450B2 | Method of treating heart failure with modified relaxin polypeptides | Emerging Cross-Sectional Technologies | 10 | Active |
| US10702588B2 | Modified relaxin polypeptides comprising a non-naturally encoded amino acid in the A chain | Emerging Cross-Sectional Technologies | 8 | Active |
| US10751391B2 | Methods of treatment using modified relaxin polypeptides comprising a non-naturally encoded amino acid | Human Necessities | 7 | Active |
| US9938333B2 | Modified leptin polypeptides and their uses | Human Necessities | 2 | Active |
| US8691940B2 | Relaxin polypeptides comprising non-naturally encoded amino acids | General | 0 | Revoked |
| US11786578B2 | Modified relaxin polypeptides and their uses | Human Necessities | 0 | Active |
| US11439710B2 | Nucleic acids encoding modified relaxin polypeptides | Emerging Cross-Sectional Technologies | 0 | Active |
| US11311605B2 | Methods of treating heart failure and fibrotic disorders using modified relaxin polypeptides | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.